Home > Cardiology > ESC 2022 > Danish study suggests starting CVD screening before age 70

Danish study suggests starting CVD screening before age 70

Presented By
Prof. Axel Cosmus Pyndt Diederichsen, Odense University Hospital, Denmark
Conference
ESC 2022
Trial
DANCAVAS
In men aged 65–74 years in Denmark, those randomised to receive an invitation for a comprehensive screening for subclinical cardiovascular disease (CVD) did not have a significantly reduced all-cause mortality after a median 5.6 years of follow-up. Patients aged between 65–69 did however benefit. The DANCAVAS study (ISRCTN12157806) was a population-based, randomised-controlled screening trial attempting to address the significant increase in the average life expectancy and incipient CVD, explained Prof. Axel Cosmus Pyndt Diederichsen (Odense University Hospital, Denmark) in his presentation [1]. The results were simultaneously published in the New England Journal of Medicine [2]. The trial aimed to evaluate the health benefits and cost effectiveness of using non-contrast CT scans to measure coronary artery calcification and identify aortic/iliac aneurysms and measur...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on